Display options
Cite
van der Vorm LN, Visser R, Huskens D, et al. Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease. Clin Kidney J. 2019;13(1):72-74doi: 10.1093/ckj/sfz076.
van der Vorm, L. N., Visser, R., Huskens, D., Veninga, A., Adams, D. L., Remijn, J. A., Hemker, H. C., Rensma, P. L., van Horssen, R., & de Laat, B. (2020). Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease. Clinical kidney journal, 13(1), 72-74. https://doi.org/10.1093/ckj/sfz076
van der Vorm, Lisa N, et al. "Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease." Clinical kidney journal vol. 13,1 (2020): 72-74. doi: https://doi.org/10.1093/ckj/sfz076
van der Vorm LN, Visser R, Huskens D, Veninga A, Adams DL, Remijn JA, Hemker HC, Rensma PL, van Horssen R, de Laat B. Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease. Clin Kidney J. 2019 Jun 17;13(1):72-74. doi: 10.1093/ckj/sfz076. eCollection 2020 Feb. PMID: 32082555; PMCID: PMC7025327.
Copy Download .nbib Format: NLM
Share it on

Clin Kidney J. 2019 Jun 17;13(1):72-74. doi: 10.1093/ckj/sfz076. eCollection 2020 Feb.

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease.

Clinical kidney journal

Lisa N van der Vorm, Ruben Visser, Dana Huskens, Alicia Veninga, Denise L Adams, Jasper A Remijn, Hendrik C Hemker, Pieter L Rensma, Remco van Horssen, Bas de Laat

Affiliations

  1. Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands.
  2. Synapse Research Institute, Maastricht, The Netherlands.
  3. Department of Clinical Chemistry and Hematology, Gelre Hospitals, Apeldoorn, The Netherlands.
  4. Department of Nephrology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
  5. Department of Clinical Chemistry, Meander Medical Center, Amersfoort, The Netherlands.
  6. Department of Clinical Chemistry and Hematology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.

PMID: 32082555 PMCID: PMC7025327 DOI: 10.1093/ckj/sfz076

[No abstract available.]

References

  1. Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):3071-8 - PubMed
  2. PLoS One. 2019 Feb 13;14(2):e0211961 - PubMed
  3. Science. 2002 Aug 16;297(5584):1176-9 - PubMed
  4. J Am Soc Nephrol. 2008 Jan;19(1):135-40 - PubMed
  5. BMJ Open. 2017 Jun 1;7(5):e014294 - PubMed
  6. Exp Ther Med. 2012 Mar;3(3):530-534 - PubMed
  7. Thromb Res. 2007;120 Suppl 1:S5-9 - PubMed
  8. Nephrol Dial Transplant. 2012 Jun;27(6):2452-7 - PubMed
  9. Curr Opin Hematol. 2007 May;14(3):284-9 - PubMed
  10. Contrib Nephrol. 2008;161:83-88 - PubMed

Publication Types